DBL Pharmaceuticals Limited arranges Company Profiling and Medicine Donation Program at BIRDEM

DBL Pharmaceuticals Limited organized a Company Profiling and Medicine Donation Program on 8 December 2025 at the Conference Hall, BIRDEM, Dhaka. The program was designed to elaborate on DBL Pharma’s vision, mission, operational excellence, and high-quality product portfolio to the esteemed Directors & Doctors of BIRDEM and Bangladesh Diabetic Association (BADAS).

The event was graced by the presence of Prof. Dr. Mirza Mahbubul Hasan, Director General, BIRDEM; Mr. Sayef Uddin, Secretary General, Bangladesh Diabetic Association (BADAS); along with all Directors and Heads of Departments of the reputed institution. Their participation underscored the collaborative intent of Hospital-Industry to strengthen the healthcare system for patients across the country.

As part of DBL Pharmaceuticals’ continued commitment to Corporate Social Responsibility (CSR), the company donated a significant number of Medicines for Patient Care, including Anti-Diabetic, Anti- Hypertensive & other products, reaffirming its dedication to support public health initiatives and improving access to essential quality treatments.

The Directors of BIRDEM applauded DBL Pharma’s generous contribution and commended the company’s management, particularly its Board of Directors, for taking such a meaningful step to support diabetic care in Bangladesh. They wished for a better future of DBL Pharma with an expectation of continuing to produce the highest Quality medicine & to reach every corner of Bangladesh

Representing DBL Pharma, Mr. Ahmed Kamrul Alam, Executive Director, Business Operations, highlighted the organization’s commitment & promise to the highest quality medicine, affordability, and patient-centric innovation at the event. Mr. Mahbubul Alam, Head of Sales & other top officials from DBL Pharma also joined the program.